Section 9003 Isn’t Broken. The Map Is.

By Cynthia Thyfault, Founder & CEO, QuantaVision
Special to The Digest

I think about a developer I watched a few years ago. The technology was real. The team was real. The feedstock was locked. They did the work most people never do — and the project still didn’t get built. When it stalled, the program took the blame. Section 9003, people said. Too slow. Doesn’t work.

That isn’t what happened. The project came apart for reasons that had nothing to do with the program — market timing, a financing gap, decisions made far upstream of USDA or the lender. But the story that stuck was the simpler one. The program failed.

I’ve heard that story too many times. It deserves to be set straight, because it’s wrong — and because rural America is about to need this program more than it has in years.

I’ve worked inside Section 9003 since it was written into the 2008 Farm Bill. Not adjacent to it. Inside it — application after application, year after year, alongside a small handful of people who have actually walked the full trail from Part One to financial close. I’ve watched what makes a project move and what makes it stall. Most of what stalls a project isn’t the program.

Here is the misconception I most want to correct. It isn’t that 9003 is “only for fuels,” though people say that. It isn’t that it’s “too slow to count on,” though people say that too. It’s the quieter belief underneath both: that 9003 isn’t relevant to what we are trying to build right now.

It is. It may be the most relevant deployment tool we have for the thing the country keeps saying it wants — a domestic bioeconomy that turns rural feedstocks and waste streams into materials, chemicals, fertilizer, and fuel, built here instead of bought from somewhere else.

Why the Program Matters Now

Here’s why this matters more now than it did even a few years ago. The producers I work with are squeezed — thin margins, and capital that costs more to borrow than it used to. Rural communities are competing hard for the kind of industrial investment that brings skilled jobs and a stable tax base. And the country keeps colliding with the same two problems: supply chains that snap under pressure, and breakthrough technologies we invent here only to watch them get built at scale somewhere else. Biomanufacturing and waste-to-value projects sit right where all of that meets — they take the feedstocks and waste streams scattered across rural America and turn them into high-value industrial products.

Positioned the right way, 9003 isn’t a niche grant program — it’s an industrial scale-up tool. It strengthens rural economies and builds the domestic capacity to make the fertilizers, chemicals, materials, and fuels we’d otherwise import. And I’ve seen what that framing does for bankability. The projects that get financed aren’t the ones with the prettiest green label; they’re the ones with durable offtake — products that win on performance, reliability, quality, or supply security. When something is genuinely better or more dependable, demand holds up across cycles, and that’s a deal a lender can actually underwrite.

The program works. What’s been missing is the map.

So if you’re a developer looking at 9003, let me give you the part the white paper doesn’t.

Map the whole path to close before you submit Part One. Not the application — the close. I watch developers get accepted into the program and only then start asking where the money comes from. That’s backwards. The work to move through 9003 — the integrated demonstration unit, the engineering, the diligence — can cost millions of dollars. That development capital is the riskiest, hardest money to raise in the entire stack. Being “in the program” does not make investors appear at your door. It never has.

Plan for that capital from day one. Know where it comes from. Build a real schedule and start raising against it the week you begin, not the month you get stuck.

And before any of that — the gate. To have a real chance, you need secured feedstock, a creditworthy offtake, and an EPC partner who will stand behind a number. You need enough research and development behind you that moving into the demonstration stage is a short step, not a leap. If you can’t yet see how the demonstration unit flows into a first commercial plant, you aren’t ready, and no program can carry you across that gap.

One more thing, and I’d underline it for 2026. Stop asking how big you can build it. Ask how small. The very large projects — the two-hundred-million, five-hundred-million, billion-dollar facilities — are not moving in this market. The projects getting built are small, profitable, and able to cash-flow as a single unit, and then repeat. Design for replication. Prove one. Build the next one cheaper. That is the path that’s actually open right now.

None of this is just my opinion, and that’s the point worth sitting with. The reforms I’ve put forward — multi-year authority so developers can plan against a real pipeline, a two-track diligence process that stops treating proven technology like first-of-a-kind risk, a written Technical Review Agreement that turns open-ended review into clear gates, year-round intake instead of batched cycles, and scoring that rewards the projects most likely to reach close and deliver durable rural benefit — are not a consultant’s wish list. They are shared by lenders, by the USDA staff who run the program, and by members of Congress on both sides of the aisle. The people closest to 9003 largely agree on what it needs. We just have to do it.

And we have to do it now. The House is fast-tracking a Farm Bill. The Senate’s version is in markup. I’ve been through enough of these since 2012 to know exactly how it ends if we’re not loud: it comes down to the wire, there is never enough money, and the programs without a clear champion get trimmed. 9003 needs resources to do what it was built to do.

There’s a bigger question underneath the Farm Bill, and almost no one is asking it out loud. The National Security Commission on Emerging Biotechnology told Congress to put at least fifteen billion dollars into rebuilding America’s biotechnology industrial base. Good. But fifteen billion into discovery with no rails to commercialize it is money poured into a bucket with no bottom. Where are the deployment programs that turn that research into operating plants? 9003 is one of the few we already have. You cannot fund the science, starve the scale-up, and call it a strategy.

This is what “industrial base” actually means. When we invent something here and build it somewhere else, we don’t just lose a factory. We lose the supply chain, the skilled jobs, the know-how, and the standing. China understood that about biotechnology twenty years ago. The projects 9003 was built to finance — a Corn Next turning corn into biodegradable materials, a Talus Ag making fertilizer from air and water at the edge of a field, a Circularity Fuels turning dairy waste into aviation-fuel intermediates — are exactly the kind of small, distributed, rural manufacturing that keeps value in the country and in the county.

I’ve spent eighteen years on this trail. I’ve watched it get blamed for falls that happened for other reasons, and I’ve watched good projects reach the summit because someone mapped the route before they took the first step. The program isn’t broken. It’s standing right where we left it, ready to do the work — if Congress funds it, if USDA runs it like the strategic tool it is, and if the developers who use it walk in with a map instead of a hope.

The mountain hasn’t moved. We just have to be willing to climb it on purpose.

About the author. Cynthia Thyfault is the Founder and CEO of QuantaVision, a firm that since 1994 has helped innovators in renewable fuels, renewable chemicals, biobased products, and value-added agriculture finance and build their projects. She has worked inside the USDA Section 9003 program since its creation in the 2008 Farm Bill and is one of its most active practitioners, guiding developers through the full path from concept to financial close. She writes and speaks regularly on financing the bioeconomy. Connect with her on LinkedIn or at quantavision.earth.

 

Category: Thought Leadership